StonvexLoading…
StonvexStonvexStonvexCore line items from ALK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.24B | $11.73B | $10.43B | $9.65B |
Operating Income | $303.00M | $570.00M | $394.00M | $70.00M |
Net Income | $100.00M | $395.00M | $235.00M | $58.00M |
EPS (Diluted) | $0.83 | $3.08 | $1.83 | $0.45 |
Total Assets | $20.36B | $19.77B | $14.61B | $14.19B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $627.00M | $1.20B | $281.00M | $338.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-444.00M | $-253.00M |
Shares Outstanding | 115.53M | 123.12M | 126.09M | 127.53M |